178 related articles for article (PubMed ID: 34487730)
21. Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
Chen L; Yang X; Zhao J; Xiong M; Almaraihah R; Chen Z; Hou T
J Exp Clin Cancer Res; 2020 May; 39(1):94. PubMed ID: 32460831
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
23. Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization.
Mukherjee S; Adhikary S; Gadad SS; Mondal P; Sen S; Choudhari R; Singh V; Adhikari S; Mandal P; Chaudhuri S; Sengupta A; Lakshmanaswamy R; Chakrabarti P; Roy S; Das C
Cell Death Dis; 2020 Dec; 11(12):1073. PubMed ID: 33323928
[TBL] [Abstract][Full Text] [Related]
24. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
[TBL] [Abstract][Full Text] [Related]
25. Suppression of the SDF‑1/CXCR4/β‑catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
Zhang T; Yang F; Li W; Liu B; Li W; Chen Z; Wang C
Oncol Rep; 2018 Sep; 40(3):1666-1674. PubMed ID: 30015971
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q
Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanism of FBXW7-mediated ubiquitination modification in nasopharyngeal carcinoma cell proliferation in vitro and in vivo.
Zhong Q; Wang Z; Kang H; Wu R
Pathol Res Pract; 2023 Apr; 244():154056. PubMed ID: 36989847
[TBL] [Abstract][Full Text] [Related]
28. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
Choi S; Lee KW; Koh HH; Park S; Yeo SY; Joh JW; Choi MS; Kim SH; Park CK; Ha SY
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3517-3534. PubMed ID: 34462784
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA AK023096 interacts with hnRNP-K and contributes to the maintenance of self-renewal in bladder cancer stem-like cells.
Zhao F; Qin S; Huang L; Ding L; Shi X; Zhong G
Exp Cell Res; 2021 Dec; 409(2):112909. PubMed ID: 34742742
[TBL] [Abstract][Full Text] [Related]
30. Ras-association domain family 1 (RASSF1A) gene regulates progression, migration and invasion of bladder cancer.
Bao Y; Liu X; Liu Y; Wang S; Wu B
Surg Oncol; 2019 Sep; 30():63-71. PubMed ID: 31500788
[TBL] [Abstract][Full Text] [Related]
31. FBP1 enhances the radiosensitivity by suppressing glycolysis via the FBXW7/mTOR axis in nasopharyngeal carcinoma cells.
Zhang P; Shao Y; Quan F; Liu L; Yang J
Life Sci; 2021 Oct; 283():119840. PubMed ID: 34298040
[TBL] [Abstract][Full Text] [Related]
32. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer.
Deng T; Shen P; Li A; Zhang Z; Yang H; Deng X; Peng X; Hu Z; Tang Z; Liu J; Hou R; Liu Z; Fang W
Theranostics; 2021; 11(16):8112-8128. PubMed ID: 34335983
[TBL] [Abstract][Full Text] [Related]
33. FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells.
Saffie R; Zhou N; Rolland D; Önder Ö; Basrur V; Campbell S; Wellen KE; Elenitoba-Johnson KSJ; Capell BC; Busino L
Cancer Res; 2020 Jun; 80(12):2498-2511. PubMed ID: 32350066
[TBL] [Abstract][Full Text] [Related]
34. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
Zhou X; Zhang P; Han H; Lei H; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6471-6481. PubMed ID: 30417565
[TBL] [Abstract][Full Text] [Related]
35. ZMYND8 preferentially binds phosphorylated EZH2 to promote a PRC2-dependent to -independent function switch in hypoxia-inducible factor-activated cancer.
Tang B; Sun R; Wang D; Sheng H; Wei T; Wang L; Zhang J; Ho TH; Yang L; Wei Q; Huang H
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593912
[TBL] [Abstract][Full Text] [Related]
36. FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer.
Ji M; Zhao Z; Li Y; Xu P; Shi J; Li Z; Wang K; Huang X; Ji J; Liu W; Liu B
Cell Death Dis; 2021 Jul; 12(8):758. PubMed ID: 34333526
[TBL] [Abstract][Full Text] [Related]
37. The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication.
Badarudeen B; Gupta R; Nair SV; Chandrasekharan A; Manna TK
J Biol Chem; 2020 Apr; 295(14):4428-4437. PubMed ID: 32086376
[TBL] [Abstract][Full Text] [Related]
38. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
39. Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target.
Urick ME; Bell DW
Cancer Med; 2020 Jun; 9(11):3863-3874. PubMed ID: 32248654
[TBL] [Abstract][Full Text] [Related]
40. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo.
Lu H; Yao B; Wen X; Jia B
BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]